Study of the BMPR2 Gene in Patients with Pulmonary Arterial Hypertension;Estudio del gen BMPR2 en pacientes con hipertensión arterial pulmonar

Archivos de Bronconeumologia

Volumn 46, Issue 3, 2010, Pages 129-134

  Portillo, Karina ^a   Santos, Salud ^b   Madrigal, Irene ^a   Blanco, Isabel ^a   Paré, Carles ^a   Borderías, Luis ^c   Peinado, Victor I ^d   Roca, Josep ^a,d   Milà, Monserrat ^a,e   Barberà, Joan Albert ^a,d  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c HOSPITAL SAN JORGE   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

Bone morphogenic protein type 2 receptor; CO diffusing capacity; Genetic screening; Mutations; Pulmonary arterial hypertension

Indexed keywords

BONE MORPHOGENETIC PROTEIN RECEPTOR 2; CARBON MONOXIDE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FAMILIAL DISEASE; FAMILY STUDY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; HETEROZYGOTE; HUMAN; LUNG ALVEOLUS; MALE; MUTATIONAL ANALYSIS; PENETRANCE; PULMONARY HYPERTENSION; SINGLE STRAND CONFORMATION POLYMORPHISM; BMPR2 GENE; ESSENTIAL HYPERTENSION; GENE; GENE EXPRESSION; GENE MUTATION; HEART HEMODYNAMICS; HEREDITARY HYPERTENSION; LUNG DIFFUSION CAPACITY; LUNG VOLUME; MIDDLE AGED; PHENOTYPE; PREVALENCE; REFERENCE VALUE; YOUNG ADULT;

ADOLESCENT; ADULT; BONE MORPHOGENETIC PROTEIN RECEPTORS, TYPE II; DNA MUTATIONAL ANALYSIS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; POINT MUTATION; YOUNG ADULT;

EID: 76749107077     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbres.2009.11.005     Document Type: Article

References (23)

1. Barberà J.A., Escribano P., Morales P., Gómez M.A., Oribe M., Martínez A., et al. Estándares asistenciales en hipertensión pulmonar. Documento de consenso elaborado por la Sociedad Española de Neumología y Cirugía Torácica (SEPAR) y la Sociedad Española de Cardiología (SEC). Arch Bronconeumol (2008) 44:87-4499
2. Rich S., Dantzker D.R., Ayres S.M., Bergofsky E.H., Brundage B.H., Detre K.M., et al. Primary pulmonary hipertensión. A national prospective study. Ann Intern Med. 107 (1987) 216-223
3. Deng Z., Morse J.H., Slager S.L., Cuervo N., Moore K.J., Venetos G., et al. Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-Ii gene. Am J Hum Genet 67 (2000) 737-744
4. Lane K.B., Machado R.D., Pauciulo M.W., Thomson J.R., Phillips JA I.I.I., Loyd J.E., et al. Heterozygous germline mutations in BMPR2, encoding a TGF-β receptor, cause familial primary pulmonary hypertension. Nat Genet 26 (2000) 81-84
5. Machado R.D., Eickelberg O., Elliott C.G., Geraci M.W., Hanaoka M., Loyd J.E., et al. Genetics and genomics of pulmonary arterial hypertension. J Am Coll Cardiol 1 (2009) 32-42
6. Thomson J.R., Machado R.D., Pauciulo M.W., Morgan N.V., Humbert M., Elliott G.C., et al. Sporadic primary pulmonary hypertension is associated with germline mutations of the gene encoding BMPR-II, a receptor member of the TGF-beta family. J Med Genet 37 (2000) 741-745
7. Koehler R., Grunig E., Pauciulo M.W., Hoeper M.M., Olschewski H., Wilkens H., et al. Low frequency of BMPR2 mutations in a German cohort of patients with sporadic idiopathic pulmonary arterial hypertension. J Med Genet 41 (2004) e127
8. Humbert M., Deng Z., Simonneau G., Barst R.J., Sitbon O., Wolf M., et al. BMPR2 germline mutations in pulmonary hypertension associated with fenfluramine derivatives. Eur Respir J 20 (2002) 518-523
9. Roberts K.E., McElroy J.J., Wong W.P.K., Yen E., Widlitz A., Barst R.J., et al. BMPR2 mutations in pulmonary arterial hypertension with congenital heart disease. Eur Respir J 24 (2004) 371-374
10. Baloira A., Vilariño C., Leiro V., and Valverde D. Mutaciones en el gen que codifica BMPR2 en pacientes con hipertensión arterial pulmonar esporádica. Arch Bronconeumol 44 (2008) 29-34
11. Grunig E., Janssen B., Mereles D., Barth U., Borst M.M., Vogt I.R., et al. Abnormal pulmonary artery pressure response in asymptomatic carriers of primary pulmonary hypertension gene. Circulation 102 (2000) 1145-1150
12. Manual SEPAR de Procedimientos. Módulo 3. Procedimientos de evaluación de Función Pulmonar. Madrid Ediciones Luzán 5, S.A; 2002.
13. Morisaki H., Nakanishi N., Kyotani S., Takashima A., Tomoike H., and Morisaki T. BMPR2 mutations found in Japanese patients with familial and sporadic primary pulmonary hypertension. Hum Mutat 23 (2004) 632
14. Elliott C.G., Glissmeyer E.W., Havlena G.T., Carlquist J., McKinney J.T., Rich S., et al. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension. Circulation 113 (2006) 2509-1
15. Austin E.D., and Loyd J.E. Genetics and mediators in pulmonary arterial hypertension. Clin Chest Med 28 (2007) 43-57 vii-viii
16. Cogan J.D., Vnencak-Jones C.L., Phillips J.A., Lane K.B., Wheeler L.A., Robbins I.M., et al. BMPR2 gene rearrangements constitute a new cause for primary pulmonary hypertension. Genet Med 7 (2005) 169-174
17. Long L., MacLean M.R., Jeffery T.K., Morecroft I., Yang X., Rudarakanchana N., et al. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice. Circ Res 98 (2006) 818-827
18. Elliott C.G. Genetics of pulmonary arterial hypertension: current and future implications. Semin Respir Crit Care Med 26 (2005) 365-371
19. Humbert M., and Trembath R.C. Genetics of pulmonary hypertension: from bench to bedside. Eur Respir J 20 (2002) 741-749
20. Peacock AJ, Rubin LJ. The genetics of pulmonary hipertensión. In: Pulmonary Circulation, diseases and their treatment. Second edition. Arnold 2004.
21. Beppu H., Ichinose F., Kawai N., Jones R.C., Yu P.B., Zapol W.M., et al. BMPR-II heterozygous mice have mild pulmonary hypertension and an impaired pulmonary vascular remodeling response to prolonged hypoxia. Am J Physiol Lung Cell Mol Physiol 287 (2004) 1241-1247
22. Sztrymf B., Coulet F., Girerd B., Yaici A., Jais X., Sitbon O., et al. Clinical outcomes of pulmonary arterial hypertension in carriers of BMPR2 mutation. Am J Respir Crit Care Med 177 (2008) 1377-1383
23. Yasunobu U., Oudiz R.J., Sun S.G., Hansen J.E., and Wasserman K. End-tidal PCO2 abnormality and exercise limitation in patients with primary pulmonary hypertension. Chest 127 (2005) 1637-1646